The medial forebrain bundle as a deep brain stimulation target for treatment resistant depression: A review of published data

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 58, Issue , 2015, Pages 59-70

  Gálvez, Juan F ^a,b   Keser, Zafer ^c   Mwangi, Benson ^a   Ghouse, Amna A ^d   Fenoy, Albert J ^d   Schulz, Paul E ^d   Sanches, Marsal ^a   Quevedo, Joao ^a   Selvaraj, Sudhakar ^a   Gajwani, Prashant ^d   Zunta Soares, Giovana ^a   Hasan, Khader M ^a   Soares, Jair C ^d  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b Facultad de Medicina   (Colombia)

^c TIRR MEMORIAL HERMANN   (United States)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

Deep brain stimulation (DBS); Medial forebrain bundle (MFB); Neuromodulation; Psychiatry; Treatment resistance depression (TRD)

Indexed keywords

DOPAMINE RECEPTOR;

ANTERIOR CINGULATE; BRAIN DEPTH STIMULATION; CAPSULA INTERNA; CEREBRAL PEDUNCLE; COGNITION; CORPUS STRIATUM; CYTOARCHITECTURE; DENTATE NUCLEUS; DIFFUSION TENSOR IMAGING; ELECTROPHYSIOLOGY; ENZYME ACTIVATION; FRACTIONAL ANISOTROPY; HUMAN; LONG TERM POTENTIATION; MEDIAL FOREBRAIN BUNDLE; MOTIVATION; NERVE CELL PLASTICITY; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; PHENOMENOLOGY; RED NUCLEUS; REVIEW; SUBTHALAMIC NUCLEUS; THALAMOCORTICAL TRACT; TRACTOGRAPHY; TREATMENT RESISTANT DEPRESSION; ADVERSE EFFECTS; ANIMAL; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; NERVE TRACT; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES;

ANIMALS; DEEP BRAIN STIMULATION; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; HUMANS; MEDIAL FOREBRAIN BUNDLE; NEURAL PATHWAYS;

EID: 84920111160     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2014.12.003     Document Type: Review

References (212)

1. Amat J., Baratta M.V., Paul E., Bland S.T., Watkins L.R., Maier S.F. Medial prefrontal cortex determines how stressor controllability affects behavior and dorsal raphe nucleus. Nat Neurosci 2005, 8(3):365-371. [Mar].
2. Anderson R.J., Frye M.A., Abulseoud O.A., Lee K.H., McGillivray J.A., Berk M., et al. Deep brain stimulation for treatment-resistant depression: efficacy, safety and mechanisms of action. Neurosci Biobehav Rev 2012, 36(8):1920-1933. [Sep].
3. Andrews R.J. Neuromodulation: advances in the next decade. Ann N Y Acad Sci 2010, 1199:212-220. [Jun].
4. Appleby B.S., Duggan P.S., Regenberg A., Rabins P.V. Psychiatric and neuropsychiatric adverse events associated with deep brain stimulation: a meta-analysis of ten years' experience. Mov Disord 2007, 22(12):1722-1728.
5. Arvanitogiannis A., Tzschentke T.M., Riscaldino L., Wise R.A., Shizgal P. Fos expression following self-stimulation of the medial prefrontal cortex. Behav Brain Res 2000, 107:123-132.
6. Ashkan K., Shotbolt P., David A.S., Samuel M. Deep brain stimulation: a return journey from psychiatry to neurology. Postgrad Med J 2013, 89(1052):323-328.
7. Beck E. The origin, course, and termination of the prefrontopontine tract in the human brain. Brain 1950, 73:368-391.
8. Berlim M.T., van den Eynde F., Tovar-Perdomo S., Daskalakis Z.J. Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials. Psychol Med 2014, 44(2):225-239.
9. Berton O., Nestler E.J. New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 2006, 7(2):137-151.
10. Bewernick B.H., Hurlemann R., Matusch A., Kayser S., Grubert C., Hadrysiewicz B., et al. Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression. Biol Psychiatry 2010, 67(2):110-116.
11. Bewernick B.H., Kayser S., Sturm V., Schlaepfer T.E. Long-term effects of nucleus accumbens deep brain stimulation in treatment-resistant depression: evidence for sustained efficacy. Neuropsychopharmacology 2012, 37(9):1975-1985.
12. Bjerknes S., Skogseid I.M., Sæhle T., Dietrichs E., Toft M. Surgical site infections after deep brain stimulation surgery: frequency, characteristics and management in a 10-year period. PLoS One 2014, 9(8):e105288.
13. Blood A.J., Losifescu D.V., Makris N., Perlis R.H., Kennedy D.N., Dougherty D.D., et al. Phenotype genotype project on addiction and mood disorders. Microstructural abnormalities in subcortical reward circuitry of subjects with major depressive disorder. PLoS One 2010, 5(11):e13945.
14. Blumenfield H., Varghese G.I., Purcaro M.J., Motelow J.E., Enev M., McNally K.A., Levin A.R., Hirsch L.J., Tikofsky R., Zubal I.G., Paige A.L., Spencer S.S. Cortical and subcortical networks in human secondarily generalized tonic-clonic seizures 2009, 132(Pt 4):999-1012. [Epub 2009 Apr 1]. 10.1093/brain/awp028.
15. Bostwick J.M., Pankratz V.S. Affective disorders and suicide risk: a reexamination. Am J Psychiatry 2000, 157(12):1925-1932.
16. Bracht T., Horn H., Strik W., Federspiel A., Schnell S., Höfle O., et al. White matter microstructure alterations of the medial forebrain bundle in melancholic depression. J Affect Disord 2014, 155:186-193.
17. Bulloch A., Williams J., Lavorato D., Patten S. Recurrence of major depressive episodes is strongly dependent on the number of previous episodes. Depress Anxiety 2014, 31(1):72-76.
18. Bürgel U., Mädler B., Honey C.R., et al. Fiber tracking with distinct software tools results in a clear diversity in anatomical fiber tract portrayal. Cen Eur Neurosurg 2009, 70:27-35.
19. Carlezon W.A., Chartoff E.H. Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation. Nat Protoc 2007, 2(11):2987-2995.
20. Carlezon W.A., Todtenkopf M.S., McPhie D.L., Pimentel P., Pliakas A.M., Stellar J.R., et al. Repeated exposure to rewarding brain stimulation downregulates GluR1 expression in the ventral tegmental area. Neuropsychopharmacology 2001, 25:234-241.
21. Carlson P.J., Diazgranados N., Nugent A.C., Ibrahim L., Luckenbaugh D.A., Brutsche N., et al. Neural correlates of rapid antidepressant response to ketamine in treatment-resistant unipolar depression: a preliminary positron emission tomography study. Biol Psychiatry 2013, 73(12):1213-1221.
22. Cassell M.D., Wright D.J. Topography of projections from the medial prefrontal cortex to the amygdala in the rat. Brain Res Bull 1986, 17(3):321-333.
23. Charlson F.J., Moran A.E., Freedman G., Norman R.E., Stapelberg N.J., Baxter A.J., et al. The contribution of major depression to the global burden of ischemic heart disease: a comparative risk assessment. BMC Med 2013, 11:250.
24. Chergui K., Svenningsson P., Nomikos G.G., Gonon F., Fredholm B.B., Svennson T.H. Increased expression of NGFI-A mRNA in the rat striatum following burst stimulation of the medial forebrain bundle. Eur J Neurosci 1997, 9(11):2370-2382.
25. Chevaleyre V., Takahashi K.A., Castillo P.E. Endocannabinoid-mediated synaptic plasticity in the CNS. Annu Rev Neurosci 2006, 29:37-76.
26. Cho Z.H., Law M., Chi J.G., Choi S.H., Park S.Y., Kammen A., et al. An anatomic review of thalamolimbic fiber tractography: ultra-high resolution direct visualization of thalamolimbic fibers anterior thalamic radiation, superolateral and inferomedial medial forebrain bundles, and newly identified septum pellucidum tract. World Neurosurg 2013, S1878-8750(13):01009-7. [Epub ahead of print]. 10.1016/j.wneu.2013.08.022.
27. Coenen V.A., Honey C.R., Hurwitz T., Rahman A.A., McMaster J., Bürgel U., et al. Medial forebrain bundle stimulation as a pathophysiological mechanism for hypomania in subthalamic nucleus deep brain stimulation for Parkinson's disease. Neurosurgery 2009, 64(6):1106-1114.
28. Coenen V.A., Schlaepfer T.E., Maedler B., Panksepp J. Cross-species affective functions of the medial forebrain bundle-implications for the treatment of affective pain and depression in humans. Neurosci Biobehav Rev 2011, 35(9):1971-1981.
29. Coenen V.A., Panksepp J., Hurwitz T.A., Urbach H., Mädler B. Human medial forebrain bundle (MFB) and anterior thalamic radiation (ATR): imaging of two major subcortical pathways and the dynamic balance of opposite affects in understanding depression. J Neuropsychiatry Clin Neurosci 2012, 24(2):223-236.
30. Creed M.C., Nobrega J.N. The role of serotonin in the antidyskinetic effects of deep brain stimulation: focus on antipsychotic-induced motor symptoms. Rev Neurosci 2013, 24(2):153-166.
31. Cryan J.F., Markou A., Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 2002, 23(5):238-245.
32. Dallapiazza R., McKisic M.S., Shah B., Elias W.J. Neuromodulation for movement disorders. Neurosurg Clin N Am 2014, 25(1):47-58.
33. De Hert M., Cohen D., Bobes J., Cetkovich-Bakmas M., Leucht S., Ndetei D.M., et al. Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. World Psychiatry 2011, 10(2):138-151.
34. Detke M.J., Rickels M., Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl) 1995, 121(1):66-72.
35. DiazGranados N., Ibrahim L.A., Brutsche N.E., Ameli R., Henter I.D., Luckenbaugh D.A., et al. Rapid resolution of suicidal ideation after a single infusion of an N-methyl-d-aspartate antagonist in patients with treatment-resistant major depressive disorder. J Clin Psychiatry 2010, 71(12):1605-1611.
36. Diazgranados N., Ibrahim L., Brutsche N.E., Newberg A., Kronstein P., Khalife S., et al. A randomized add-on trial of an N-methyl-d-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry 2010, 67(8):793-802.
37. Dikmen S.S., Heaton R.K., Grant I., Temkin N.R. Test-retest reliability and practice effects of expanded Halstead-Reitan neuropsychological test battery. J Int Neuropsychol Soc 1999, 5(4):346-356.
38. Dodd S., Horgan D., Malhi G.S., Berk M. To combine or not to combine? A literature review of antidepressant combination therapy. J Affect Disord 2005, 89(1-3):1-11.
39. Engelhardt E., Madeira Moreira D., Laks J. Cerebrocerebellar system and Arnold's bundle, a tractographic study: preliminary results. Dement Neuropsychol 2010, 4(4):293-299.
40. Falowski S.M., Sharan A., Reyes B.A., Sikkema C., Szot P., Van Bockstaele E.J. An evaluation of neuroplasticity and behavior after deep brain stimulation of the nucleus accumbens in an animal model of depression. Neurosurgery 2011, 69(6):1281-1290.
41. Fava M. Diagnosis and definition of treatment-resistant depression. Biol Psychiatry 2003, 53(8):649-659.
42. Fenoy A.J., Simpson R.K. Management of device-related wound complications in deep brain stimulation surgery. J Neurosurg 2012, 116(6):1324-1332.
43. Fenoy A.J., Simpson R.K. Risks of common complications in deep brain stimulation surgery: management and avoidance. J Neurosurg 2014, 120(1):132-139.
44. Fenoy A.J., Goetz L., Chabardès S., Xia Y. Deep brain stimulation: are astrocytes a key driver behind the scene?. CNS Neurosci Ther 2014, 20(3):191-201.
45. Ferrari A.J., Charlson F.J., Norman R.E., Patten S.B., Freedman G., Murray C.J., et al. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med 2013, 10(11):e1001547.
46. Fix J. High-yield(TM) neuroanatomy 2008, LWW. Fourth ed.
47. Forbes E.E. Where's the fun in that? Broadening the focus on reward function in depression. Biol Psychiatry 2009, 66(3):199-200.
48. Friedman A., Frankel M., Flaumenhaft Y., Merenlender A., Pinhasov A., Feder Y., et al. Programmed acute electrical stimulation of ventral tegmental area alleviates depressive-like behavior. Neuropsychopharmacology 2009, 34(4):1057-1066.
49. Funkiewiez A., Ardouin C., Krack P., Fraix V., Van Blercom N., Xie J., et al. Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease. Mov Disord 2003, 18(5):524-530.
50. Galati S., D'Angelo V., Olivola E., Marzetti F., Di Giovanni G., Stanzione P., et al. Acute inactivation of the medial forebrain bundle imposes oscillations in the SNr: a challenge for the 6-OHDA model?. Exp Neurol 2010, 225(2):294-301.
51. Gaynes B.N., Warden D., Trivedi M.H., Wisniewski S.R., Fava M., Rush A.J. What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression. Psychiatr Serv 2009, 60(11):1439-1445.
52. George M.S., Ketter T.A., Parekh P.I., Horwitz B., Herscovitch P., Post R.M. Brain activity during transient sadness and happiness in healthy women. Am J Psychiatry 1995, 152(3):341-351.
53. George M.S., Schlaepfer T., Padberg F., Fitzgerald P.B. Brain stimulation treatments for depression. World J Biol Psychiatry 2014, 15(2):167-168.
54. German D.C., Holloway F.A. Directionality of rewarding impulses within the medial forebrain bundle self-stimulation system of the rat. Science 1973, 179(4080):1345-1347.
55. Gersner R., Toth E., Isserles M., Zangen A. Site-specific antidepressant effects of repeated subconvulsive electrical stimulation: potential role of brain-derived neurotrophic factor. Biol Psychiatry 2010, 67(2):125-132.
56. Greenberg B.D., Askland K.D., Carpenter L.L. The evolution of deep brain stimulation for neuropsychiatric disorders. Front Biosci 2008, 13:4638-4648.
57. Grubert C., Hurlemann R., Bewernick B.H., Kayser S., Hadrysiewicz B., Axmacher N., et al. Neuropsychological safety of nucleus accumbens deep brain stimulation for major depression: effects of 12-month stimulation. World J Biol Psychiatry 2011, 12(7):516-527.
58. Guillery R.W. Degeneration in the hypothalamic connexions of the albino rat. J Anat 1957, 91:91-115.
59. Gurdjian E.S. The diencephalon of the albino rat. J Comp Neurol 1927, 43:1-114.
60. Haber S.N., Knutson B. The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology 2010, 35(1):4-26.
61. Hamani C., Nóbrega J.N. Deep brain stimulation in clinical trials and animal models of depression. Eur J Neurosci 2010, 32(7):1109-1117.
62. Hamani C., Nobrega J.N. Preclinical studies modeling deep brain stimulation for depression. Biol Psychiatry 2012, 72(11):916-923.
63. Hamani C., Temel Y. Deep brain stimulation for psychiatric disease: contributions and validity of animal models. Sci Transl Med 2012, 4(142):142rv8.
64. Hamani C., Diwan M., Macedo C.E., Brandão M.L., Shumake J., Gonzalez-Lima F., et al. Antidepressant-like effects of medial prefrontal cortex deep brain stimulation in rats. Biol Psychiatry 2010, 67(2):117-124.
65. Hamani C., Nobrega J.N., Lozano A.M. Deep brain stimulation in clinical practice and in animal models. Clin Pharmacol Ther 2010, 88(4):559-562.
66. Hamani C., Mayberg H., Stone S., Laxton A., Haber S., Lozano A.M. The subcallosal cingulate gyrus in the context of major depression. Biol Psychiatry 2011, 69(4):301-308.
67. Hamani C., Moro E., Lozano A.M. The pedunculopontine nucleus as a target for deep brain stimulation. J Neural Transm 2011, 118(10):1461-1468.
68. Hardenacke K., Shubina E., Bührle C.P., Zapf A., Lenartz D., Klosterkötter J., et al. Deep brain stimulation as a tool for improving cognitive functioning in Alzheimer's dementia: a systematic review. Front Psychiatry 2013, 4:159.
69. Hariz M., Blomstedt P., Zrinzo L. Future of brain stimulation: new targets, new indications, new technology. Mov Disord 2013, 28(13):1784-1792.
70. Hauptman J.S., DeSalles A.A., Espinoza R., Sedrak M., Ishida W. Potential surgical targets for deep brain stimulation in treatment-resistant depression. Neurosurg Focus 2008, 25(1):E3.
71. Heijnen W.T., Birkenhäger T.K., Wierdsma A.I., van den Broek W.W. Antidepressant pharmacotherapy failure and response to subsequent electroconvulsive therapy: a meta-analysis. J Clin Psychopharmacol 2010, 30(5):616-619.
72. Holtzheimer P.E., Kelley M.E., Gross R.E., Filkowski M.M., Garlow S.J., Barrocas A., et al. Subcallosal cingulate deep brain stimulation for treatment-resistant unipolar and bipolar depression. Arch Gen Psychiatry 2012, 69(2):150-158.
73. Hurley K.M., Herbert H., Moga M.M., Saper C.B. Efferent projections of the infralimbic cortex of the rat. J Comp Neurol 1991, 308(2):249-276.
74. Hurwitz T.A., Mandat T., Forster B., et al. Tract identification by novel MRI signal changes following stereotactic anterior capsulotomy. Stereotact Funct Neurosurg 2006, 84:228-235.
75. Ibrahim L., Diazgranados N., Luckenbaugh D.A., Machado-Vieira R., Baumann J., Mallinger A.G., et al. Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression. Prog Neuropsychopharmacol Biol Psychiatry 2011, 35(4):1155-1159.
76. Ito M. Excitability of medial forebrain bundle neurons during self-stimulating behavior. J Neurophysiol 1972, 35:652-664.
77. Jiménez F., Velasco F., Salin-Pascual R., Hernández J.A., Velasco M., Criales J.L., Nicolini H. A patient with a resistant major depression disorder treated with deep brain stimulation in the inferior thalamic peduncle. Neurosurgery 2005, 57(3):585-593. [Sep].
78. Jiménez F., Nicolini H., Lozano A.M., Piedimonte F., Salín R., Velasco F. Electrical stimulation of the inferior thalamic peduncle in the treatment of major depression and obsessive compulsive disorders. World Neurosurg 2013, 80(3-4):S30.e17-25.
79. Johansen-Berg H., Gutman D.A., Behrens T.E., Matthews P.M., Rushworth M.F., et al. Anatomical connectivity of the subgenual cingulate region targeted with deep brain stimulation for treatment-resistant depression. Cereb Cortex 2008, 18(6):1374-1383.
80. Jones D.K., Knösche T.R., Turner R. White matter integrity, fiber count, and other fallacies: the do's and don'ts of diffusion MRI. Neuroimage 2013, 73(C):239-254.
81. Kaba H., Saito H., Otsuka K., Seto K. Ventrolateral medullary neurons projecting to the medial preoptic/anterior hypothalamic area through the medial forebrain bundle: an electrophysiological study in the rat. Exp Brain Res 1986, 63(2):369-374.
82. Kalia L.V., Brotchie J.M., Fox S.H. Novel nondopaminergic targets for motor features of Parkinson's disease: review of recent trials. Mov Disord 2013, 28(2):131-144.
83. Kalivas P.W., Volkow N.D. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 2005, 162:1403-1413.
84. Keefe K.A., Zigmond M.J., Abercrombie E.D. Extracellular dopamine in striatum: influence of nerve impulse activity in medial forebrain bundle and local glutamatergic input. Neuroscience 1992, 47(2):325-332.
85. Kellner C.H., Knapp R.G., Petrides G., Rummans T.A., Husain M.M., Rasmussen K., et al. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry 2006, 63(12):1337-1344.
86. Kennedy S.H., Giacobbe P., Rizvi S.J., Placenza F.M., Nishikawa Y., Mayberg H.S., et al. Deep brain stimulation for treatment-resistant depression: follow-up after 3 to 6years. Am J Psychiatry 2011, 168(5):502-510.
87. Keser Z., Yozbatiran N., Francisco G.E., Hasan K.M. A note on the mapping and quantification of the human brain corticospinal tract. Eur J Radiol 2014, 83(9):1703-1705.
88. Kessler R.C., Berglund P., Demler O., Jin R., Merikangas K.R., Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005, 62(6):593-602.
89. Kessler R.C., Demler O., Frank R.G., Olfson M., Pincus H.A., Walters E.E., et al. Prevalence and treatment of mental disorders, 1990 to 2003. N Engl J Med 2005, 352(24):2515-2523.
90. Kleiner-Fisman G., Herzog J., Fisman D.N., Tamma F., Lyons K.E., Pahwa R., et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord 2006, 21(Suppl. 14):S290-S304.
91. Korgaonkar M.S., Grieve S.M., Koslow S.H., Gabrieli J.D., Gordon E., Williams L.M. Loss of white matter integrity in major depressive disorder: evidence using tract-based spatial statistical analysis of diffusion tensor imaging. Hum Brain Mapp 2011, 32(12):2161-2171.
92. Krieg W.J.S. The hypothalamus of the albino rat. J Comp Neurol 1923, 55:19-89.
93. Krishnan V., Nestler E.J. The molecular neurobiology of depression. Nature 2008, 455(7215):894-902.
94. Kuhr W.G., Wightman R.M., Rebec G.V. Dopaminergic neurons: simultaneous measurements of dopamine release and single-unit activity during stimulation of the medial forebrain bundle. Brain Res 1987, 418(1):122-128.
95. Kulisevsky J., Litvan I., Berthier M.L., Pascual-Sedano B., Paulsen J.S., Cummings J.L. Neuropsychiatric assessment of Gilles de la Tourette patients: comparative study with other hyperkinetic and hypokinetic movement disorders. Mov Disord 2001, 16(6):1098-1104.
96. le Gros Clark W.E. The termination of ascending tracts in the thalamus of the Macaque monkey. J Anat 1936, 71(Pt 1):7-40.
97. Leung Y.W., Flora D.B., Gravely S., Irvine J., Carney R.M., Grace S.L. The impact of premorbid and postmorbid depression onset on mortality and cardiac morbidity among patients with coronary heart disease: meta-analysis. Psychosom Med 2012, 74(8):786-801.
98. Levy D., Shabat-Simon M., Shalev U., Barnea-Ygael N., Cooper A., Zangen A. Repeated electrical stimulation of reward-related brain regions affects cocaine but not "natural" reinforcement. J Neurosci 2007, 27(51):14179-14189. [Dec 19].
99. Li L., Ma N., Li Z., Tan L., Liu J., Gong G., et al. Prefrontal white matter abnormalities in young adult with major depressive disorder: a diffusion tensor imaging study. Brain Res 2007, 1168:124-128.
100. Li B., Piriz J., Mirrione M., Chung C., Proulx C.D., Schulz D., et al. Synaptic potentiation onto habenula neurons in the learned helplessness model of depression. Nature 2011, 470(7335):535-539.
101. Liao Y., Huang X., Wu Q., Yang C., Kuang W., Du M., et al. Is depression a disconnection syndrome? Meta-analysis of diffusion tensor imaging studies in patients with MDD. J Psychiatry Neurosci 2013, 38:49-56.
102. Liebrenz M., Borgeat A., Leisinger R., Stohler R. Intravenous ketamine therapy in a patient with a treatment-resistant major depression. Swiss Med Wkly 2007, 137(15-16):234-236.
103. Lozano A.M., Mayberg H.S., Giacobbe P., Hamani C., Craddock R.C., Kennedy S.H. Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biol Psychiatry 2008, 64(6):461-467.
104. Lozano A.M., Giacobbe P., Hamani C., Rizvi S.J., Kennedy S.H., Kolivakis T.T., et al. A multicenter pilot study of subcallosal cingulate area deep brain stimulation for treatment-resistant depression. J Neurosurg 2012, 116(2):315-322.
105. Lu L., Grimm J.W., Shaham Y., Hope B.T. Molecular neuroadaptations in the accumbens and ventral tegmental area during the first 90days of forced abstinence from cocaine self-administration in rats. J Neurochem 2003, 85:1604-1613.
106. Machado-Vieira R., Salvadore G., Diazgranados N., Zarate C.A. Ketamine and the next generation of antidepressants with a rapid onset of action. Pharmacol Ther 2009, 123(2):143-150.
107. Mai J.K., Paxinos G., Voss T. Atlas of the human brain 2008, Elsevier Inc, New York. 3rd ed.
108. Malone D.A. Use of deep brain stimulation in treatment-resistant depression. Cleve Clin J Med 2010, 77(Suppl. 3):S77-S80.
109. Malone D.A., Dougherty D.D., Rezai A.R., Carpenter L.L., Friehs G.M., Eskandar E.N., et al. Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression. Biol Psychiatry 2009, 65(4):267-275.
110. Mantione M., van de Brink W., Schuurman P.R., Denys D. Smoking cessation and weight loss after chronic deep brain stimulation of the nucleus accumbens: therapeutic and research implications: case report. Neurosurgery 2010, 66:E218.
111. Marvel C.L., Paradiso S. Cognitive and neurological impairment in mood disorders. Psychiatr Clin North Am 2004, 27(1):19-36.
112. Mayberg H.S., Liotti M., Brannan S.K., McGinnis S., Mahurin R.K., Jerabek P.A., et al. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry 1999, 156(5):675-682.
113. Mayberg H.S., Lozano A.M., Voon V., McNeely H.E., Seminowicz D., et al. Deep brain stimulation for treatment-resistant depression. Neuron 2005, 45(5):651-660.
114. McCabe C., Cowen P.J., Harmer C.J. Neural representation of reward in recovered depressed patients. Psychopharmacology (Berl) 2009, 205(4):667-677.
115. McIntyre R.S., Filteau M.J., Martin L., Patry S., Carvalho A., Cha D.S., et al. Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach. J Affect Disord 2014, 156:1-7.
116. McNeely H.E., Mayberg H.S., Lozano A.M., Kennedy S.H. Neuropsychological impact of Cg25 deep brain stimulation for treatment-resistant depression: preliminary results over 12months. J Nerv Ment Dis 2008, 196(5):405-410.
117. Mendoza J., Foundas A. Clinical neuroanatomy: a neurobehavioral approach 2007, Springer. First ed.
118. Meng H., Wang Y., Huang M., Lin W., Wang S., Zhang B. Chronic deep brain stimulation of the lateral habenula nucleus in a rat model of depression. Brain Res 2011, 1422:32-38.
119. Mentzel C.L., Tenback D.E., Tijssen M.A., Visser-Vandewalle V.E., van Harten P.N. Efficacy and safety of deep brain stimulation in patients with medication-induced tardive dyskinesia and/or dystonia: a systematic review. J Clin Psychiatry 2012, 73(11):1434-1438.
120. Meyer M. A study of efferent connexions of the frontal lobe in the human brain after leucotomy. Brain 1949, 72:265-296.
121. Miocinovic S., Somayajula S., Chitnis S., Vitek J.L. History, applications, and mechanisms of deep brain stimulation. JAMA Neurol 2013, 70(2):163-171.
122. Müller U.J., Voges J., Steiner J., Galazky I., Heinze H.J., Möller M., et al. Deep brain stimulation of the nucleus accumbens for the treatment of addiction. Ann N Y Acad Sci 2013, 1282:119-128.
123. Muneyuki I. Activation and inhibition of the lateral hypothalamic neurones elicited by medial forebrain bundle stimulation. J Physiol 1976, 254(1):109-128.
124. Murphy M.L., Frodl T. Meta-analysis of diffusion tensor imaging studies shows altered fractional anisotropy occurring in distinct brain areas in association with depression. Biol Mood Anxiety Disord 2011, 1:3.
125. Murray C.J., Vos T., Lozano R., Naghavi M., Flaxman A.D., Michaud C., et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380(9859):2197-2223.
126. Murrough J.W. Ketamine as a novel antidepressant: from synapse to behavior. Clin Pharmacol Ther 2012, 91(2):303-309.
127. Nahas Z., Marangell L.B., Husain M.M., Rush A.J., Sackeim H.A., Lisanby S.H., et al. Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J Clin Psychiatry 2005, 66(9):1097-1104.
128. Nauta W.J. Hippocampal projections and related neural pathways to the midbrain in the cat. Brain 1958, 81:319-340.
129. Neafsey E.J., Hurley-Gius K.M., Arvanitis D. The topographical organization of neurons in the rat medial frontal, insular and olfactory cortex projecting to the solitary nucleus, olfactory bulb, periaqueductal gray and superior colliculus. Brain Res 1986, 377(2):261-270.
130. Neafsey E.J., Terreberry R.R., Hurley K.M., Ruit K.G., Frysztal R.J. Anterior cingulate in rodents. Connections, visceral control functions, and implications for emotion 1993, 208-223. Birkhauser, Boston. B.A. Vogt, M. Gabriel (Eds.).
131. Nelson J.C., Papakostas G.I. Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials. Am J Psychiatry 2009, 166(9):980-991.
132. Nestler E.J., Carlezon W.A. The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 2006, 59(12):1151-1159.
133. Nestler E.J., Hyman S.E. Animal models of neuropsychiatric disorders. Nat Neurosci 2010, 13(10):1161-1169.
134. Nieuwenhuys R., Geeraedts L.M., Veening J.C. The medial forebrain bundle of the rat. I General introduction. J Comp Neurol. 1982, 206:49-81.
135. Nugent A.C., Diazgranados N., Carlson P.J., Ibrahim L., Luckenbaugh D.A., Brutsche N., et al. Neural correlates of rapid antidepressant response to ketamine in bipolar disorder. Bipolar Disord 2014, 16(2):119-128.
136. Okun M.S., Rodriguez R.L., Mikos A., Miller K., Kellison I., Kirsch-Darrow L., et al. Deep brain stimulation and the role of the neuropsychologist. Clin Neuropsychol 2007, 21(1):162-189.
137. Olds M.E. Effect of intraventricular norepinephrine on neuron activity in the medial forebrain bundle during self-stimulation behavior. Brain Res 1974, 80(3):461-477.
138. Olds M.E. Unit responses in the medial forebrain bundle to rewarding stimulation in the hypothalamus. Brain Res 1974, 80:479-495.
139. Olds M.E. Enhanced dopamine receptor activation in accumbens and frontal cortex has opposite effects on medial forebrain bundle self-stimulation. Neuroscience 1990, 35(2):313-325.
140. Pagnin D., de Queiroz V., Pini S., Cassano G.B. Efficacy of ECT in depression: a meta-analytic review. J ECT 2004, 20(1):13-20.
141. Palkovitz M., Zaborsky L. Neural connections of the hypothalamus. Anatomy of the Hypothalamus 1979, vol. 1:379-509. Marcel Decker, New York. P.J. Morgane, J. Panksepp (Eds.).
142. Panksepp J. Affective neuroscience: the foundations of human and animal emotions 1998, New York, Oxford University Press, Oxford, UK.
143. Panksepp J. Affective consciousness: core emotional feelings in animals and humans. Conscious Cogn 2005, 14:30-80.
144. Paradiso S., Lamberty G.J., Garvey M.J., Robinson R.G. Cognitive impairment in the euthymic phase of chronic unipolar depression. J Nerv Ment Dis 1997, 185(12):748-754.
145. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 2007, Elsevier Academic Press, New York. Sixth ed.
146. Peciña S., Smith K.S., Berridge K.C. Hedonic hot spots in the brain. Neuroscientist 2006, 12(6):500-511.
147. Pierce R.C., Kumaresan V. The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse?. Neurosci Biobehav Rev 2006, 30(2):215-238.
148. Pillolla G., Melis M., Perra S., Muntoni A.L., Gessa G.L., Pistis M. Medial forebrain bundle stimulation evokes endocannabinoid-mediated modulation of ventral tegmental area dopamine neuron firing in vivo. Psychopharmacology (Berl) 2007, 191(3):843-853.
149. Pizzagalli D.A., Holmes A.J., Dillon D.G., Goetz E.L., Birk J.L., Bogdan R., et al. Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder. Am J Psychiatry 2009, 166(6):702-710.
150. Prudic J., Haskett R.F., McCall W.V., Isenberg K., Cooper T., Rosenquist P.B., et al. Pharmacological strategies in the prevention of relapse after electroconvulsive therapy. J ECT 2013, 29(1):3-12.
151. Puigdemont D., Pérez-Egea R., Portella M.J., Molet J., de Diego-Adeliño J., Gironell A., et al. Deep brain stimulation of the subcallosal cingulate gyrus: further evidence in treatment-resistant major depression. Int J Neuropsychopharmacol 2012, 15(1):121-133.
152. Rabheru K. Maintenance electroconvulsive therapy (M-ECT) after acute response: examining the evidence for who, what, when, and how?. J ECT 2012, 28(1):39-47.
153. Rose D., Fleischmann P., Wykes T., Leese M., Bindman J. Patients' perspectives on electroconvulsive therapy: systematic review. BMJ 2003, 326(7403):1363.
154. Rush A.J., Thase M.E., Dubé S. Research issues in the study of difficult-to-treat depression. Biol Psychiatry 2003, 53(8):743-753.
155. Rush A.J., Marangell L.B., Sackeim H.A., George M.S., Brannan S.K., Davis S.M., et al. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol Psychiatry 2005, 58(5):347-354.
156. Sacchet M.D., Prasad G., Foland-Ross L.C., Joshi S.H., Hamilton J.P., Thompson P.M., et al. Structural abnormality of the corticospinal tract in major depressive disorder. Biol Mood Anxiety Disord 2014, 4:8.
157. Sackeim H.A., Prudic J., Devanand D.P., Decina P., Kerr B., Malitz S. The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacol 1990, 10(2):96-104.
158. Salvadore G., Cornwell B.R., Sambataro F., Latov D., Colon-Rosario V., Carver F., et al. Anterior cingulate desynchronization and functional connectivity with the amygdala during a working memory task predict rapid antidepressant response to ketamine. Neuropsychopharmacology 2010, 35(7):1415-1422.
159. Sartorius A., Henn F.A. Deep brain stimulation of the lateral habenula in treatment resistant major depression. Med Hypotheses 2007, 69(6):1305-1308.
160. Sartorius A., Kiening K.L., Kirsch P., von Gall C.C., Haberkorn U., Unterberg A.W., et al. Remission of major depression under deep brain stimulation of the lateral habenula in a therapy-refractory patient. Biol Psychiatry 2010, 67(2):e9-e11.
161. Savitz J., Drevets W.C. Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide. Neurosci Biobehav Rev 2009, 33:699-771.
162. Schenk S., Snow S. Sensitization to cocaine's motor activating properties produced by electrical kindling of the medial prefrontal cortex but not of the hippocampus. Brain Res 1994, 659:17-22.
163. Schlaepfer T.E., Bewernick B.H. Neuromodulation for treatment resistant depression: state of the art and recommendations for clinical and scientific conduct. Brain Topogr 2014, 27(1):12-19.
164. Schlaepfer T.E., Cohen M.X., Frick C., Kosel M., Brodesser D., Axmacher N., et al. Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology 2008, 33(2):368-377.
165. Schlaepfer T.E., Bewernick B.H., Kayser S., Mädler B., Coenen V.A. Rapid effects of deep brain stimulation for treatment-resistant major depression. Biol Psychiatry 2013, 73(12):1204-1212.
166. Schlaepfer T.E., Bewernick B.H., Kayser S., Hurlemann R., Coenen V.A. Deep brain stimulation of the human reward system for major depression-rationale. Outcomes and outlook. Neuropsychopharmacology 2014, 39(6):1303-1314.
167. Schneider T.M., Beynon C., Sartorius A., Unterberg A.W., Kiening K.L. Deep brain stimulation of the lateral habenular complex in treatment-resistant depression: traps and pitfalls of trajectory choice. Neurosurgery 2013, 72(2 Suppl. Operative):ons184-93.
168. Schultz S.K., Castillo C.S., Kosier J.T., Robinson R.G. Generalized anxiety and depression assessment over 2years after stroke. Am J Geriatr Psychiatry 1997, 5(3):229-237.
169. Sesack S.R., Pickel V.M. Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area. J Comp Neurol 1992, 320:145-160.
170. Sexton C.E., Mackay C.E., Ebmeier K.P. A systematic review of diffusion tensor imaging studies in affective disorders. Biol Psychiatry 2009, 66:814-823.
171. Shizgal P., Schindler D., Rompré P.P. Forebrain neurons driven by rewarding stimulation of the medial forebrain bundle in the rat: comparison of psychophysical and electrophysiological estimates of refractory periods. Brain Res 1989, 499(2):234-248.
172. Sinnamon H.M., Galer B.S. Head movements elicited by electrical stimulation of the anteromedial cortex of the rat. Physiol Behav 1984, 33(2):185-190.
173. Snell R. Clinical neuroanatomy 2009, LWW. Seventh ed.
174. Spielmans G.I., Berman M.I., Linardatos E., Rosenlicht N.Z., Perry A., Tsai A.C. Adjunctive atypical antipsychotic treatment for major depressive disorder: a meta-analysis of depression, quality of life, and safety outcomes. PLoS Med 2013, 10(3):e1001403.
175. Stamford J.A., Kruk Z.L., Millar J. Accommodation of rat nigrostriatal dopamine neurones to high frequency electrical stimulation of the median forebrain bundle: in vivo voltammetric data. Neurosci Lett 1987, 82(2):172-176.
176. Standring S. Grays anatomy. The anatomical basis of clinical practice 2005, Elsevier Churchill Livinstone., London. 39th edition.
177. ten Doesschate M.C., Bockting C.L., Koeter M.W., Schene A.H. DELTA study group. Prediction of recurrence in recurrent depression: a 5.5-year prospective study. J Clin Psychiatry 2010, 71(8):984-991.
178. Tierney T.S., Vasudeva V.S., Weir S., Hayes M.T. Neuromodulation for neurodegenerative conditions. Front Biosci (Elite Ed) 2013, 5:490-499.
179. Treadway M.T., Zald D.H. Reconsidering anhedonia in depression: lessons from translational neuroscience. Neurosci Biobehav Rev 2011, 35(3):537-555.
180. Tredici G., Barajon I., Pizzini G., et al. The organization of corticopontine fibres in man. Acta Anat (Basel) 1990, 137:320-323.
181. Tremblay L.K., Naranjo C.A., Graham S.J., Herrmann N., Mayberg H.S., Hevenor S., et al. Functional neuroanatomical substrates of altered reward processing in major depressive disorder revealed by a dopaminergic probe. Arch Gen Psychiatry 2005, 62(11):1228-1236.
182. Tsai S.T., Lin S.H., Lin S.Z., Chen J.Y., Lee C.W., Chen S.Y. Neuropsychological effects after chronic subthalamic stimulation and the topography of the nucleus in Parkinson's disease. Neurosurgery 2007, 61(5):E1024-E1029.
183. Tye S.J., Frye M.A., Lee K.H. Disrupting disordered neurocircuitry: treating refractory psychiatric illness with neuromodulation. Mayo Clin Proc 2009, 84(6):522-532.
184. Tye S.J., Miller A.D., Blaha C.D. Ventral tegmental ionotropic glutamate receptor stimulation of nucleus accumbens tonic dopamine efflux blunts hindbrain-evoked phasic neurotransmission: implications for dopamine dysregulation disorders. Neuroscience 2013, 252:337-345.
185. Valencia-Alfonso C.E., Luigjes J., Smolders R., Cohen M.X., Levar N., Mazaheri A., et al. Effective deep brain stimulation in heroin addiction: a case report with complementary intracranial electroencephalogram. Biol Psychiatry 2012, 71:e35-e37.
186. van der Heyden J.A. Circling behaviour induced by electrical stimulation of the medial forebrain bundle, importance of stimulus parameters and dopaminergic processes. Pharmacol Biochem Behav 1984, 21(4):567-574.
187. van der Kooy D., McGinty J.F., Koda L.Y., Gerfen C.R., Bloom F.E. Visceral cortex: a direct connection from prefrontal cortex to the solitary nucleus in rat. Neurosci Lett 1982, 33(2):123-127.
188. Vertes R.P. Interactions among the medial prefrontal cortex, hippocampus and midline thalamus in emotional and cognitive processing in the rat. Neuroscience 2006, 142(1):1-20.
189. Vidailhet M., Jutras M.F., Roze E., Grabli D. Deep brain stimulation for dystonia. Handb Clin Neurol 2013, 116:167-187.
190. Vorel S.R., Liu X., Hayes R.J., Spector J.A., Gardner E.L. Relapse to cocaine-seeking after hippocampal theta burst stimulation. Science 2001, 292:1175-1178.
191. Waraczynski M.A. The central extended amygdala network as a proposed circuit underlying reward valuation. Neurosci Biobehav Rev 2006, 30(4):472-496.
192. Warden D., Rush A.J., Trivedi M.H., Fava M., Wisniewski S.R. The STAR*D Project results: a comprehensive review of findings. Curr Psychiatry Rep 2007, 9(6):449-459.
193. Wauquier A., Niemegeers C.J. Intracranial self-stimulation in rats as a function of various stimulus parameters IV. Influence of amphetamine on medial forebrain bundle stimulation with monopolar electrodes. Psychopharmacologia 1974, 34(3):265-274.
194. Wauquier A., Niemegeers C.J. Intracranial self-stimulation in rats as a function of various stimulus parameters VI. Influence of fentanyl, piritramide, and morphine on medial forebrain bundle stimulation with monopolar electrodes. Psychopharmacologia 1976, 46(2):179-183.
195. Wauquier A., Niemergeers C.J. Intracranial self-stimulation in rats as a function of various stimulus parameters V. Influence of cocaine on medial forebrain bundle stimulation with monopolar electrodes. Psychopharmacologia 1974, 38(3):201-210.
196. Whiteford H.A., Degenhardt L., Rehm J., Baxter A.J., Ferrari A.J., Erskine H.E., et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet 2013, 382(9904):1575-1586.
197. Williams N.R., Okun M.S. Deep brain stimulation (DBS) at the interface of neurology and psychiatry. J Clin Invest 2013, 123(11):4546-4556.
198. Willner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology (Berl) 1997, 134(4):319-329.
199. Willner P., Mitchell P.J. The validity of animal models of predisposition to depression. Behav Pharmacol 2002, 13(3):169-188.
200. Wise R.A. Addictive drugs and brain stimulation reward. Annu Rev Neurosci 1996, 19:319-340.
201. Wise R.A., Munn E. Effects of repeated amphetamine injections on lateral hypothalamic brain stimulation reward and subsequent locomotion. Behav Brain Res 1993, 55:195-201.
202. Yeomans J.S. Two substrates for medial forebrain bundle self-stimulation: myelinated axons and dopamine axons. Neurosci Biobehav Rev 1989, 13(2-3):91-98.
203. You Z.B., Tzschentke T.M., Brodin E., Wise R.A. Electrical stimulation of the prefrontal cortex increases cholecystokinin, glutamate, and dopamine release in the nucleus accumbens: an in vivo microdialysis study in freely moving rats. J Neurosci 1998, 18:6492-6500.
204. You Z.B., Chen Y.Q., Wise R.A. Dopamine and glutamate release in the nucleus accumbens and ventral tegmental area of rat following lateral hypothalamic self-stimulation. Neuroscience 2001, 107:629-639.
205. Younce J.R., Albaugh D.L., Shih Y.Y. Deep brain stimulation with simultaneous FMRI in rodents. J Vis Exp 2014, 84:e51271.
206. Zahm D.S. The evolving theory of basal forebrain functional-anatomical 'macrosystems'. Neurosci Biobehav Rev 2006, 30(2):148-172.
207. Zarate C.A., Singh J., Manji H.K. Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder. Biol Psychiatry 2006, 59(11):1006-1020.
208. Zarate C., Machado-Vieira R., Henter I., Ibrahim L., Diazgranados N., Salvadore G. Glutamatergic modulators: the future of treating mood disorders?. Harv Rev Psychiatry 2010, 18(5):293-303.
209. Zarate C.A., Brutsche N., Laje G., Luckenbaugh D.A., Venkata S.L., Ramamoorthy A., et al. Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression. Biol Psychiatry 2012, 72(4):331-338.
210. Zarate C., Duman R.S., Liu G., Sartori S., Quiroz J., Murck H. New paradigms for treatment-resistant depression. Ann N Y Acad Sci 2013, 1292:21-31.
211. Zhou H., Xu J., Jiang J. Deep brain stimulation of nucleus accumbens on heroin-seeking behaviors: a case report. Biol Psychiatry 2011, 69:e41-e42.
212. Zhu X., Wang X., Xiao J., Zhong M., Liao J., Yao S. Altered white matter integrity in first-episode, treatment-naive young adults with major depressive disorder: a tract-based spatial statistics study. Brain Res 2011, 1369:223-229.